Lung Cancer

Working to alleviate lung cancer stigma helps patients to receive quality cancer care without the added burden of self-inflicted distress. Here’s how.

From the moment a lung nodule is found, thoracic navigators are instrumental in coordinating patient care until active treatment is complete.

The process of screening and/or detection to the actual diagnosis of lung cancer involves multiple specialties and diagnostic testing, which can be quite daunting for an individual and his/her family.

Osimertinib in the adjuvant treatment setting significantly improves disease-free survival (DFS) in patients with localized non–small-cell lung cancer (NSCLC) with an epidermal growth factor receptor (EGFR) mutation.

A strong screening program can make a big difference. Here are tips for your program from the Maine Lung Cancer Coalition.

The decline in mortality from lung cancer has gone from 2% per year to 4% overall. Here’s how we’ve accomplished the decline.